Correlation Between Goldman Sachs and Pharmaceuticals Ultrasector

Can any of the company-specific risk be diversified away by investing in both Goldman Sachs and Pharmaceuticals Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Goldman Sachs and Pharmaceuticals Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Goldman Sachs Small and Pharmaceuticals Ultrasector Profund, you can compare the effects of market volatilities on Goldman Sachs and Pharmaceuticals Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Goldman Sachs with a short position of Pharmaceuticals Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Goldman Sachs and Pharmaceuticals Ultrasector.

Diversification Opportunities for Goldman Sachs and Pharmaceuticals Ultrasector

0.77

Correlation Coefficient

Goldman Sachs  Pharmaceuticals Ultrasector

Poor diversification

The 3 months correlation between Goldman and Pharmaceuticals is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Goldman Sachs Small and Pharmaceuticals Ultrasector Pr in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmaceuticals Ultrasector and Goldman Sachs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Goldman Sachs Small are associated (or correlated) with Pharmaceuticals Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmaceuticals Ultrasector has no effect on the direction of Goldman Sachs i.e., Goldman Sachs and Pharmaceuticals Ultrasector go up and down completely randomly.

Pair Corralation between Goldman Sachs and Pharmaceuticals Ultrasector

Assuming the 90 days horizon Goldman Sachs is expected to generate 1.1 times less return on investment than Pharmaceuticals Ultrasector. But when comparing it to its historical volatility, Goldman Sachs Small is 1.58 times less risky than Pharmaceuticals Ultrasector. It trades about 0.08 of its potential returns per unit of risk. Pharmaceuticals Ultrasector Profund is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  2,187  in Pharmaceuticals Ultrasector Profund on May 10, 2025 and sell it today you would earn a total of  106.00  from holding Pharmaceuticals Ultrasector Profund or generate 4.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Goldman Sachs Small  vs.  Pharmaceuticals Ultrasector Pr

Goldman Sachs Small

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in Goldman Sachs Small are ranked lower than 6 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Goldman Sachs is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pharmaceuticals Ultrasector

Risk-Adjusted Performance

Soft

Compared to the overall equity markets, risk-adjusted returns on investments in Pharmaceuticals Ultrasector Profund are ranked lower than 4 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong forward indicators, Pharmaceuticals Ultrasector is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Goldman Sachs and Pharmaceuticals Ultrasector

The main advantage of trading using opposite Goldman Sachs and Pharmaceuticals Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Goldman Sachs position performs unexpectedly, Pharmaceuticals Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmaceuticals Ultrasector will offset losses from the drop in Pharmaceuticals Ultrasector's long position.

The idea behind Goldman Sachs Small and Pharmaceuticals Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.